FM10 860
e133
Reply to Jae Heon Kimand Benjamin I. Chung’s Letter to the Editor re: JulienDagenais, Matthew J.Maurice, Pascal Mouracade, Onder Kara, ErcanMalkoc, Jihad J. Kaouk. Excisional PrecisionMatters: Understanding the Influence of Excisional Volume Loss on Renal Function After Partial Nephrectomy. EurUrol 2017;72:168–70 http://dx.doi.org/10.1016/j.eururo.2017.05.018J. Dagenais, J.H. Kaouk
e135
Re: Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive Metastatic Bladder Cancer. J Clin Oncol 2017;35:48–55 Knowing HER2 Status is Not Enough: A Molecular Subtype Approach to Bladder Cancer is Also Needed http://dx.doi.org/10.1016/j.eururo.2017.05.027P. Eriksson, G. Sjödahl, F. Liedberg
e137
Reply to Pontus Eriksson, Gottfrid Sjödahl, and Fredrik Liedberg’s Letter to the Editor re: Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive Metastatic Bladder Cancer. J Clin Oncol 2017;35:48–55. Knowing HER2 Status is Not Enough: A Molecular Subtype Approach to Bladder Cancer is Also Needed Protein Expression to Predict Outcome to Targeted Therapy in Bladder Cancer: Too Little, Too Late? http://dx.doi.org/10.1016/j.eururo.2017.05.025T. Powles, A. Gómez de Liaño, C. Ackerman
e139
Re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790–807 Benign Müllerian Lesions in the Urinary Bladder: Endometriosis, Endocervicosis, Endosalpingiosis, and Müllerianosis http://dx.doi.org/10.1016/j.eururo.2017.05.029R. Montironi, S. Gasparrini, A. Lopez-Beltran, L. Cheng, F. Massari, F. Montorsi, M. Scarpelli
e142
Reply to Rodolfo Montironi, Silvia Gasparrini, Antonio Lopez-Beltran, et al’s Letter to the Editor re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790–807. Benign Müllerian Lesions in the Urinary Bladder: Endometriosis, Endocervicosis, Endosalpingiosis, and Müllerianosis http://dx.doi.org/10.1016/j.eururo.2017.05.028U. Leone Roberti Maggiore, S. Ferrero, M. Candiani, E. Somigliana, P. Viganò, P. Vercellini
e143
Congress Calendare147
Addendum to “Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response” [Eur Urol 2017;71:776–87]E.B. Ylitalo, E. Thysell, E. Jernberg, M. Lundholm, S. Crnalic, L. Egevad, P. Stattin, A. Widmark,
A. Bergh, P. Wikström
e148
Corrigendum re: “Percutaneous Nephrolithotomy: Update, Trends, and Future Directions for Simultaneous Supine Percutaneous Nephrolithotomy and Retrograde Ureterolithotripsy in the Galdakao-modified Supine Valdivia Position for Large Proximal Ureteral Calculi” [Eur Urol 2017;71:837–8]T.-Y. Huang, K.M. Feng, I.-S. Lo
e u r o p e a n u r o l o g y , vo l . 7 2 , n o . 5 , No v emb e r 2 0 1 7
The illustrations on the cover of this issue are taken from the article byMelvin L.K. Chua,
Winnie Lo, Melania Pintilie, Jure Murgic, Emilie Lalonde, Vinayak Bhandari, et al,
A Prostate Cancer ‘‘
Nimbosus
’’: Genomic Instability and
SChLAP1
Dysregulation
Underpin Aggression of Intraductal and Cribriform Subpathologies, which is published
on pp. 665–674 of this issue.
Addendum
Corrigendum